AI Terminal
Eckert & Ziegler Strahlen- und Medizintechnik AG
Regulatory Filings • Feb 4, 2021
130_rns_2021-02-04_7bda3ec6-e35b-4ed3-a157-2e673e3c9e95.html
Regulatory Filings
Open in ViewerOpens in native device viewer
News Details
Ad-hoc | 4 February 2021 19:28
Eckert & Ziegler: PENTIXAPHARM Lead Candidate PENTIXAFOR Can Go in Phase III Study, EMA says
Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Miscellaneous
Eckert & Ziegler: PENTIXAPHARM Lead Candidate PENTIXAFOR Can Go in Phase III Study, EMA says
04-Feb-2021 / 19:28 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP – a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
Berlin, 04.02.2021 – Würzburg based PENTIXAPHARM GmbH, an associate of Eckert & Ziegler AG (ISIN DE0005659700), has received confirmation from the European Medicines Agency (EMA) that its lead candidate PENTIXAFOR may be tested directly in a phase III clinical study. The agency said that there are “sufficient safety data available to initiate a phase III trial” for the Gallium-68 labelled radiodiagnostic which detects CXCR4-positiv solid tumors and CXCR4-positive hematological malignancies.
Contact:
Eckert & Ziegler AG
Karolin Riehle, Investor Relations
Robert-Rössle-Str. 10, 13125 Berlin, Germany
Tel. +49 30 941084-138, [email protected], www.ezag.de
Information and Explanation of the Issuer to this News:
Details about PENTIXAFOR and the content of the EMA advice will be provided in the next days in a separate PENTIXAPHARM press release.
04-Feb-2021 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de
| Language: | English |
| Company: | Eckert & Ziegler Strahlen- und Medizintechnik AG |
| Robert-Rössle-Str.10 | |
| 13125 Berlin | |
| Germany | |
| Phone: | +49 30 941084-138 |
| Fax: | +49 30 941084-112 |
| E-mail: | [email protected] |
| Internet: | www.ezag.de |
| ISIN: | DE0005659700 |
| WKN: | 565970 |
| Indices: | SDAX |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: | 1166049 |
| End of Announcement | DGAP News Service |